About Peplib
Peplib is a Healthcare company based in Boston (United States) founded in 2017 by Li Sean, Cheng Lei, and Gong Huanzhang. Provider of peptide drug discovery and development services for global pharmaceutical industries. Peplib has raised $34.22 million across 1 funding round from investors including Fortune Capital, CAS Investment Partners and CDH. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Chemical Proteomics. Its competitors include Liberation Labs, NJ Bio and Seranova; 2 of its 3 listed competitors have raised funding.
Company details
Peplib was founded in 2017 in Boston, United States, within the biotech sector. Services in peptide drug discovery and development are offered to global pharmaceutical and biotech companies. A novel technology platform based on cyclic peptides is employed to encode and compress information, supporting drug innovation processes. Operations focus on advancing peptide-based therapeutics for industry partners.
- Headquarters Boston, United States
- Founders Li Sean, Cheng Lei, Gong Huanzhang
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website peplib.com
- Social LinkedIn
- Total Equity Funding$34.22M (USD)
in 1 rounds
- Latest Funding Round$34.22M (USD), Series A
May 2021
- InvestorsFortune Capital
& 5 more
Funding Insights of Peplib
Peplib has successfully raised a total of $34.22M through 1 strategic funding round. The most recent funding activity was a Series A round of $34.22 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.22M
- Total Rounds 1
- Last Round Series A — $34.22M
- First Round $34.22M
(May 2021)
- Investors Count 6
All 1 funding rounds of Peplib with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $34.22M | Series A | – | CDH |
6 investors in total: 6 institutional.
Investors in Peplib
Peplib has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Fortune Capital, CAS Investment Partners and CDH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and private debt firm focused on multiple sectors | cdhfund.com | Kowloon, China | ||
Healthcare startups are funded by HLC venture capital firm. | hlc.com.cn | Shanghai, China | ||
| cowincapital.com.cn | ||||
Early-stage venture capital investments are provided by Legend Star. | legendstar.cn | Beijing, China | ||
Provides stock market training and financial guidance services in India. | 2016 | fortunecapital.co.in | Pune, India | |
Diversified asset management is provided across various classes. | 2012 | casinvestmentpartners.com | New York, United States |
Investor details for Peplib
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Peplib
8 people are tracked at Peplib (8 in leadership).
| Name | Role | Group |
|---|---|---|
Li Sean | Co-Founder | Leadership |
Cheng Lei | Co-Founder | Leadership |
Gong Huanzhang | Co-Founder | Leadership |
Li Yilong | Director, Medicinal Chemistry | Leadership |
Huiqing Liu | Senior Vice President | Leadership |
Xiangqun Li | Co-Founder & CEO | Leadership |
Huanzhang Gong | Co-Founder & SVP | Leadership |
Liu Wenge | Executive Director, Pharmacology Department | Leadership |
Complete people profiles for Peplib
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Peplib
2 dated milestones of Peplib across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Peplib is founded.
- Funding First funding round of $34.2M.
Competitors of Peplib
Peplib has 3 listed competitors in our database, 2 of them funded. They include Liberation Labs, NJ Bio and Seranova.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| liberationlabs.com | 2022 | New York, United States | $107.61M | Fermentation products are manufactured and commercialized via CRO services. | ||
| njbio.com | 2018 | North Brunswick, United States | 84 | Clinical development services are provided for biotechnology applications. | ||
| seranovabio.com | 2020 | New Haven, United States | $10M | CRO offering chemical proteomics services for preclinical development of drug |
Detailed competitors of Peplib
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Peplib (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Peplib
Peplib was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Peplib is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Peplib is a funded company, having raised a total of $34.22M across 1 funding round to date. The company's 1st funding round was a Series A of $34.22M, raised on May 2021.
Peplib was founded in 2017 in Boston, United States, within the biotech sector. Services in peptide drug discovery and development are offered to global pharmaceutical and biotech companies. A novel technology platform based on cyclic peptides is employed to encode and compress information, supporting drug innovation processes. Operations focus on advancing peptide-based therapeutics for industry partners.
Peplib's top competitors include Liberation Labs, NJ Bio and Seranova.
Peplib has 6 investors. Key investors include Fortune Capital, CAS Investment Partners, CDH, Honghui Fund, and Cowin Capital.